Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Quality attributes of partially hydrolyzed collagen in a liquid formulation used for skin care. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detection....
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 6 de septiembre de 2022 In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: Marzo 2021 Poor survival in COVID-19 associated with Lymphopenia and Higher Neutrophile-Lymphocyte ratio Ver más
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 20 Septiembre 2019 Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Validation of a cell proliferation assay to assess the potency of a Dialyzable Leucocyte Extract intended for batch release....
-
UDIBI
admin_udibi3, , 2023, Sin categorizar, 0
Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. VER MÁS